Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviz Technologies (INVZ) Liabilities and Shareholders Equity (2019 - 2025)

Innoviz Technologies' Liabilities and Shareholders Equity history spans 7 years, with the latest figure at $138.5 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 4.85% year-over-year to $138.5 million; the TTM value through Dec 2025 reached $745.2 million, down 20.21%, while the annual FY2025 figure was $138.5 million, 4.85% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $138.5 million at Innoviz Technologies, up from $132.0 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $327.2 million in Q4 2021 and bottomed at $132.0 million in Q4 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $219.2 million (2023), against an average of $214.5 million.
  • The largest annual shift saw Liabilities and Shareholders Equity surged 350.96% in 2021 before it plummeted 39.77% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $327.2 million in 2021, then fell by 21.94% to $255.4 million in 2022, then decreased by 14.17% to $219.2 million in 2023, then tumbled by 39.77% to $132.0 million in 2024, then increased by 4.85% to $138.5 million in 2025.
  • Per Business Quant, the three most recent readings for INVZ's Liabilities and Shareholders Equity are $138.5 million (Q4 2025), $132.0 million (Q4 2024), and $219.2 million (Q4 2023).